The vascular smooth muscle cell in arterial pathology: A cell that can take on multiple roles

Cardiovascular Research

Volumn 95, Issue 2, 2012, Pages 194-204

  Lacolley, Patrick ^a   Regnault, Véronique ^a   Nicoletti, Antonino ^b   Li, Zhenlin ^c   Michel, Jean Baptiste ^b  

^a UNIVERSITÉ DE LORRAINE   (France)

^b BICHAT HOSPITAL   (France)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

Ageing; Atherosclerosis; Hypertension; Protease; Serpin; Signalling

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; VASCULOTROPIN;

APOPTOSIS; ATHEROMA; BLOOD VESSEL CALCIFICATION; CELL AGING; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; DISEASE COURSE; ENDOCYTOSIS; GENE EXPRESSION; HUMAN; HYPERTENSION; IMMUNE RESPONSE; INTRACELLULAR SIGNALING; PATHOGENESIS; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN AMIDE; ANIMALS; ARTERIES; ATHEROSCLEROSIS; CELL AGING; HUMANS; MYOCYTES, SMOOTH MUSCLE; SIGNAL TRANSDUCTION;

EID: 84862903745     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvs135     Document Type: Review

References (135)

1. Plissonnier D, Henaff M, Poncet P, Paris E, Tron F, Thuillez C et al. Involvement of antibody-dependent apoptosis in graft rejection. Transplantation 2000;69: 2601-2608. (Pubitemid 30482028)
2. Plissonnier D, Nochy D, Poncet P, Mandet C, Hinglais N, Bariety J et al. Sequential immunological targeting of chronic experimental arterial allograft. Transplantation 1995;60:414-424.
3. Michel JB, Thaunat O, Houard X, Meilhac O, Caligiuri G, Nicoletti A. Topological determinants and consequences of adventitial responses to arterial wall injury. Arterioscler Thromb Vasc Biol 2007;27:1259-1268. (Pubitemid 46809413)
4. Alexander MR, Owens GK. Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. Annu Rev Physiol 2012;74:1-28.
5. Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 2004;84:767-801. (Pubitemid 38823766)
6. Tang Y, Yang X, Friesel RE, Vary CP, Liaw L. Mechanisms of TGF-beta-induced differentiation in human vascular smooth muscle cells. J Vasc Res 2011;48:485-494.
7. Jin S, Hansson EM, Tikka S, Lanner F, Sahlgren C, Farnebo F et al. Notch signaling regulates platelet-derived growth factor receptor-beta expression in vascular smooth muscle cells. Circ Res 2008;102:1483-1491.
8. Tsaousi A, Williams H, Lyon CA, Taylor V, Swain A, Johnson JL et al. Wnt4/betacatenin signaling induces VSMC proliferation and is associated with intimal thickening. Circ Res 2011;108:427-436.
9. Hoffman BD, Grashoff C, Schwartz MA. Dynamic molecular processes mediate cellular mechanotransduction. Nature 2011;475:316-323.
10. Ingber DE. Tensegrity-based mechanosensing from macro to micro. Prog Biophys Mol Biol 2008;97:163-179.
11. Schiffrin EL. Circulatory therapeutics: use of antihypertensive agents and their effects on the vasculature. J Cell Mol Med 2010;14:1018-1029.
12. Bezie Y, Lamaziere JM, Laurent S, Challande P, Cunha RS, Bonnet J et al. Fibronectin expression and aortic wall elastic modulus in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 1998;18:1027-1034. (Pubitemid 28323586)
13. Louis H, Kakou A, Regnault V, Labat C, Bressenot A, Gao-Li J et al. Role of alpha1beta1-integrin in arterial stiffness and angiotensin-induced arterial wall hypertrophy in mice. Am J Physiol Heart Circ Physiol 2007;293:H2597-H2604. (Pubitemid 47605909)
14. Welser JV, Lange N, Singer CA, Elorza M, Scowen P, Keef KD et al. Loss of the alpha7 integrin promotes extracellular signal-regulated kinase activation and altered vascular remodeling. Circ Res 2007;101:672-681. (Pubitemid 47494098)
15. Michel JB. Anoikis in the cardiovascular system: known and unknown extracellular mediators. Arterioscler Thromb Vasc Biol 2003;23:2146-2154.
16. Delbosc S, Haloui M, Louedec L, Dupuis M, Cubizolles M, Podust VN et al. Proteomic analysis permits the identification of new biomarkers of arterial wall remodeling in hypertension. Mol Med 2008;14:383-394.
17. Qiu H, Zhu Y, Sun Z, Trzeciakowski JP, Gansner M, Depre C et al. Short communication: vascular smooth muscle cell stiffness as a mechanism for increased aortic stiffness with aging. Circ Res 2010;107:615-619.
18. Lacolley P, Safar ME, Regnault V, Frohlich ED. Angiotensin II, mechanotransduction, and pulsatile arterial hemodynamics in hypertension. Am J Physiol Heart Circ Physiol 2009;297:H1567-H1575.
19. Kim HR, Appel S, Vetterkind S, Gangopadhyay SS, Morgan KG. Smooth muscle signalling pathways in health and disease. J Cell Mol Med 2008;12:2165-2180.
20. Carrillo-Sepulveda MA, Barreto-Chaves ML. Phenotypic modulation of cultured vascular smooth muscle cells: a functional analysis focusing on MLC and ERK1/2 phosphorylation. Mol Cell Biochem 2010;341:279-289.
21. Touyz RM, El Mabrouk M, He G, Wu XH, Schiffrin EL. Mitogen-activated protein/extracellular signal-regulated kinase inhibition attenuates angiotensin II-mediated signaling and contraction in spontaneously hypertensive rat vascular smooth muscle cells. Circ Res 1999;84:505-515. (Pubitemid 29138587)
22. Navedo MF, Nieves-Cintron M, Amberg GC, Yuan C, Votaw VS, Lederer WJ et al. AKAP150 is required for stuttering persistent Ca2+ sparklets and angiotensin II-induced hypertension. Circ Res 2008;102:e1-e11. (Pubitemid 351651131)
23. Waitkus-Edwards KR, Martinez-Lemus LA, Wu X, Trzeciakowski JP, Davis MJ, Davis GE et al. alpha(4)beta(1) Integrin activation of L-type calcium channels in vascular smooth muscle causes arteriole vasoconstriction. Circ Res 2002;90:473-480. (Pubitemid 34633918)
24. Wu X, Mogford JE, Platts SH, Davis GE, Meininger GA, Davis MJ. Modulation of calcium current in arteriolar smooth muscle by alphav beta3 and alpha5 beta1 integrin ligands. J Cell Biol 1998;143:241-252. (Pubitemid 28480532)
25. D'Angelo EK, Singer HA, Rembold CM. Magnesium relaxes arterial smooth muscle by decreasing intracellular Ca2+ without changing intracellular Mg2+. J Clin Invest 1992;89:1988-1994.
26. He Y, Yao G, Savoia C, Touyz RM. Transient receptor potential melastatin 7 ion channels regulate magnesium homeostasis in vascular smooth muscle cells: role of angiotensin II. Circ Res 2005;96:207-215. (Pubitemid 40209368)
27. Pritchard TJ, Parvatiyar M, Bullard DP, Lynch RM, Lorenz JN, Paul RJ. Transgenic mice expressing Na+-K+-ATPase in smooth muscle decreases blood pressure. Am J Physiol Heart Circ Physiol 2007;293:H1172-H1182. (Pubitemid 47254219)
28. Guilluy C, Bregeon J, Toumaniantz G, Rolli-Derkinderen M, Retailleau K, Loufrani L et al. The Rho exchange factor Arhgef1 mediates the effects of angiotensin II on vascular tone and blood pressure. Nat Med 2010;16:183-190.
29. Miano JM, Long X, Fujiwara K. Serum response factor: master regulator of the actin cytoskeleton and contractile apparatus. Am J Physiol Cell Physiol 2007;292:C70-C81. (Pubitemid 46115122)
30. Han YJ, Hu WY, Chernaya O, Antic N, Gu L, Gupta M et al. Increased myosin light chain kinase expression in hypertension: regulation by serum response factor via an insertion mutation in the promoter. Mol Biol Cell 2006;17:4039-4050. (Pubitemid 44330886)
31. Wu YJ, Bond M, Sala-Newby GB, Newby AC. Altered S-phase kinase-associated protein-2 levels are a major mediator of cyclic nucleotide-induced inhibition of vascular smooth muscle cell proliferation. Circ Res 2006;98:1141-1150. (Pubitemid 43948100)
32. Werth D, Grassi G, Konjer N, Dapas B, Farra R, Giansante C et al. Proliferation of human primary vascular smooth muscle cells depends on serum response factor. Eur J Cell Biol 2010;89:216-224.
33. Horita HN, Simpson PA, Ostriker A, Furgeson S, Van Putten V, Weiser-Evans MC et al. Serum response factor regulates expression of phosphatase and tensin homolog through a MicroRNA network in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2011;31:2909-2919.
34. Ding M, Xie Y, Wagner RJ, Jin Y, Carrao AC, Liu LS et al. Adiponectin induces vascular smooth muscle cell differentiation via repression of mammalian target of rapamycin complex 1 and FoxO4. Arterioscler Thromb Vasc Biol 2011;31:1403-1410.
35. Davis-Dusenbery BN, Wu C, Hata A. Micromanaging vascular smooth muscle cell differentiation and phenotypic modulation. Arterioscler Thromb Vasc Biol 2011;31: 2370-2377.
36. Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, Muth AN et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009;460: 705-710.
37. Albinsson S, Skoura A, Yu J, DiLorenzo A, Fernandez-Hernando C, Offermanns S et al. Smooth muscle miRNAs are critical for post-natal regulation of blood pressure and vascular function. PLoS One 2011;6:e18869.
38. Xin M, Small EM, Sutherland LB, Qi X, McAnally J, Plato CF et al. MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev 2009;23:2166-2178.
39. Ceolotto G, Papparella I, Bortoluzzi A, Strapazzon G, Ragazzo F, Bratti P et al. Interplay between miR-155, AT1R A1166C polymorphism, and AT1R expression in young untreated hypertensives. Am J Hypertens 2011;24:241-246.
40. Virmani R, Avolio AP, Mergner WJ, Robinowitz M, Herderick EE, Cornhill JF et al. Effect of aging on aortic morphology in populations with high and low prevalence of hypertension and atherosclerosis. Comparison between occidental and Chinese communities. Am J Pathol 1991;139:1119-1129.
41. Fu Z, Wang M, Gucek M, Zhang J, Wu J, Jiang L et al. Milk fat globule protein epidermal growth factor-8: a pivotal relay element within the angiotensin II and monocyte chemoattractant protein-1 signaling cascade mediating vascular smooth muscle cells invasion. Circ Res 2009;104:1337-1346.
42. Wu X, Zou Y, Zhou Q, Huang L, Gong H, Sun A et al. Role of Jagged1 in arterial lesions after vascular injury. Arterioscler Thromb Vasc Biol 2011;31:2000-2006.
43. Chamorro-Jorganes A, Calleros L, Griera M, Saura M, Luengo A, Rodriguez-Puyol D et al. Fibronectin upregulates cGMP-dependent protein kinase type Ibeta through C/EBP transcription factor activation in contractile cells. Am J Physiol Cell Physiol 2011; 300:C683-C691.
44. Bell RD, Deane R, Chow N, Long X, Sagare A, Singh I et al. SRF and myocardin regulate LRP-mediated amyloid-beta clearance in brain vascular cells. Nat Cell Biol 2009; 11:143-153.
45. Boucher P, Li WP, Matz RL, Takayama Y, Auwerx J, Anderson RG et al. LRP1 functions as an atheroprotective integrator of TGFbeta and PDFG signals in the vascular wall: implications for Marfan syndrome. PLoS One 2007;2:e448.
46. Krug AW, Allenhofer L, Monticone R, Spinetti G, Gekle M, Wang M et al. Elevated mineralocorticoid receptor activity in aged rat vascular smooth muscle cells promotes a proinflammatory phenotype via extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase and epidermal growth factor receptor-dependent pathways. Hypertension 2010;55:1476-1483.
47. Wang Y, Ait-Oufella H, Herbin O, Bonnin P, Ramkhelawon B, Taleb S et al. TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice. J Clin Invest 2010;120:422-432.
48. Wang M, Zhao D, Spinetti G, Zhang J, Jiang LQ, Pintus G et al. Matrix metalloproteinase 2 activation of transforming growth factor-beta1 (TGF-beta1) and TGF-beta1-type II receptor signaling within the aged arterial wall. Arterioscler Thromb Vasc Biol 2006;26:1503-1509. (Pubitemid 44288975)
49. Spinetti G, Wang M, Monticone R, Zhang J, Zhao D, Lakatta EG. Rat aortic MCP-1 and its receptor CCR2 increase with age and alter vascular smooth muscle cell function. Arterioscler Thromb Vasc Biol 2004;24:1397-1402. (Pubitemid 39050431)
50. Hogg ME, Vavra AK, Banerjee MN, Martinez J, Jiang Q, Keefer LK et al. The role of estrogen receptor alpha and beta in regulating vascular smooth muscle cell proliferation is based on sex. J Surg Res 2011;173:e1-10.
51. Straface E, Vona R, Gambardella L, Ascione B, Marino M, Bulzomi P et al. Cell sex determines anoikis resistance in vascular smooth muscle cells. FEBS Lett 2009;583: 3448-3454.
52. Yang D, McCrann DJ, Nguyen H, St Hilaire C, DePinho RA, Jones MR et al. Increased polyploidy in aortic vascular smooth muscle cells during aging is marked by cellular senescence. Aging Cell 2007;6:257-260. (Pubitemid 46455069)
53. McCrann DJ, Yang D, Chen H, Carroll S, Ravid K. Upregulation of Nox4 in the aging vasculature and its association with smooth muscle cell polyploidy. Cell Cycle 2009;8: 902-908.
54. Liu GH, Barkho BZ, Ruiz S, Diep D, Qu J, Yang SL et al. Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome. Nature 2011;472: 221-225.
55. Capell BC, Olive M, Erdos MR, Cao K, Faddah DA, Tavarez UL et al. A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse model. Proc Natl Acad Sci USA 2008;105:15902-15907.
56. Ragnauth CD,Warren DT, Liu Y, McNair R, Tajsic T, Figg N et al. Prelamin A acts to accelerate smooth muscle cell senescence and is a novel biomarker of human vascular aging. Circulation 2010;121:2200-2210.
57. Schlatmann TJ, Becker AE. Pathogenesis of dissecting aneurysm of aorta. Comparative histopathologic study of significance of medial changes. Am J Cardiol 1977;39: 21-26. (Pubitemid 8022420)
58. Kapustin AN, Davies JD, Reynolds JL, McNair R, Jones GT, Sidibe A et al. Calcium regulates key components of vascular smooth muscle cell-derived matrix vesicles to enhance mineralization. Circ Res 2011;109:e1-e12.
59. Johnson KA, Polewski M, Terkeltaub RA. Transglutaminase 2 is central to induction of the arterial calcification program by smooth muscle cells. Circ Res 2008;102: 529-537. (Pubitemid 351416752)
60. Burton DG, Matsubara H, Ikeda K. Pathophysiology of vascular calcification: pivotal role of cellular senescence in vascular smooth muscle cells. Exp Gerontol 2010;45: 819-824.
61. Laurent S, Boutouyrie P, Lacolley P. Structural and genetic bases of arterial stiffness. Hypertension 2005;45:1050-1055. (Pubitemid 40770302)
62. Osborne-Pellegrin M, Labat C, Mercier N, Challande P, Lacolley P. Changes in aortic stiffness related to elastic fiber network anomalies in the Brown Norway rat during maturation and aging. Am J Physiol Heart Circ Physiol 2010;299:H144-H152.
63. Basta G, Schmidt AM, De Caterina R. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res 2004;63:582-592. (Pubitemid 39078671)
64. Belmin J, Corman B, Merval R, Tedgui A. Age-related changes in endothelial permeability and distribution volume of albumin in rat aorta. Am J Physiol 1993;264: H679-H685. (Pubitemid 23109855)
65. Regnault V, Perret-Guillaume C, Kearney-Schwartz A, Max JP, Labat C, Louis H et al. Tissue factor pathway inhibitor: a new link among arterial stiffness, pulse pressure, and coagulation in postmenopausal women. Arterioscler Thromb Vasc Biol 2011;31: 1226-1232.
66. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W Jr, Rosenfeld ME et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1994;89:2462-2478. (Pubitemid 24142837)
67. Virmani R, Kolodgie FD, Burke AP, Finn AV, Gold HK, Tulenko TN et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 2005;25:2054-2061. (Pubitemid 41416300)
68. Michel JB, Virmani R, Arbustini E, Pasterkamp G. Intraplaque haemorrhages as the trigger of plaque vulnerability. Eur Heart J 2011;32:1977-1985, 1985a, 1985b, 1985c.
69. Olofsson SO, Boren J. Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis. J Intern Med 2005;258:395-410. (Pubitemid 41546555)
70. Khalil MF, Wagner WD, Goldberg IJ. Molecular interactions leading to lipoprotein retention and the initiation of atherosclerosis. Arterioscler Thromb Vasc Biol 2004; 24:2211-2218. (Pubitemid 39658020)
71. Muir EM, Bowyer DE. Dependence of fluid-phase pinocytosis in arterial smoothmuscle cells on temperature, cellular ATP concentration and the cytoskeletal system. Biochem J 1983;216:467-473. (Pubitemid 14244309)
72. Sprague EA, Kelley JL, Suenram CA, Valente AJ, Abreu-Macomber M, Schwartz CJ. Stimulation of albumin endocytosis by cationized ferritin in cultured aortic smooth muscle cells. Am J Pathol 1985;121:433-443. (Pubitemid 16183362)
73. Mitra S, Deshmukh A, Sachdeva R, Lu J, Mehta JL. Oxidized low-density lipoprotein and atherosclerosis implications in antioxidant therapy. Am J Med Sci 2011;342: 135-142.
74. Camino-Lopez S, Llorente-Cortes V, Sendra J, Badimon L. Tissue factor induction by aggregated LDL depends on LDL receptor-related protein expression (LRP1) and Rho A translocation in human vascular smooth muscle cells. Cardiovasc Res 2007; 73:208-216. (Pubitemid 44937191)
75. Moore KJ, Freeman MW. Scavenger receptors in atherosclerosis: beyond lipid uptake. Arterioscler Thromb Vasc Biol 2006;26:1702-1711. (Pubitemid 44305322)
76. Lillis AP, Van Duyn LB, Murphy-Ullrich JE, Strickland DK. LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies. Physiol Rev 2008;88:887-918.
77. Choi SH, Harkewicz R, Lee JH, Boullier A, Almazan F, Li AC et al. Lipoprotein accumulation in macrophages via toll-like receptor-4-dependent fluid phase uptake. Circ Res 2009;104:1355-1363.
78. Kolb S, Vranckx R, Huisse MG, Michel JB, Meilhac O. The phosphatidylserine receptor mediates phagocytosis by vascular smooth muscle cells. J Pathol 2007;212: 249-259. (Pubitemid 47010059)
79. Riviere C, Boudghene FP, Gazeau F, Roger J, Pons JN, Laissy JP et al. Iron oxide nanoparticle-labeled rat smooth muscle cells: cardiac MR imaging for cell graft monitoring and quantitation. Radiology 2005;235:959-967. (Pubitemid 40695895)
80. Bennett MR, Gibson DF, Schwartz SM, Tait JF. Binding and phagocytosis of apoptotic vascular smooth muscle cells is mediated in part by exposure of phosphatidylserine. Circ Res 1995;77:1136-1142.
81. Fries DM, Lightfoot R, Koval M, Ischiropoulos H. Autologous apoptotic cell engulfment stimulates chemokine secretion by vascular smooth muscle cells. Am J Pathol 2005;167:345-353. (Pubitemid 43026092)
82. Hokamura K, Inaba H, Nakano K, Nomura R, Yoshioka H, Taniguchi K et al. Molecular analysis of aortic intimal hyperplasia caused by Porphyromonas gingivalis infection in mice with endothelial damage. J Periodontal Res 2010;45:337-344.
83. Rong JX, Shapiro M, Trogan E, Fisher EA. Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading. Proc Natl Acad Sci USA 2003;100:13531-13536. (Pubitemid 37444776)
84. Andreeva ER, Pugach IM, Orekhov AN. Subendothelial smooth muscle cells of human aorta express macrophage antigen in situ and in vitro. Atherosclerosis 1997; 135:19-27. (Pubitemid 27469692)
85. Beranek JT. CD68 is not a macrophage-specific antigen. Ann Rheum Dis 2005;64: 342-343; author reply 343-344.
86. Inaba H, Hokamura K, Nakano K, Nomura R, Katayama K, Nakajima A et al. Upregulation of S100 calcium-binding protein A9 is required for induction of smooth muscle cell proliferation by a periodontal pathogen. FEBS Lett 2009;583:128-134.
87. Yu H, Clarke MC, Figg N, Littlewood TD, Bennett MR. Smooth muscle cell apoptosis promotes vessel remodeling and repair via activation of cell migration, proliferation, and collagen synthesis. Arterioscler Thromb Vasc Biol 2011;31:2402-2409.
88. Clarke MC, Littlewood TD, Figg N, Maguire JJ, Davenport AP, Goddard M et al. Chronic apoptosis of vascular smooth muscle cells accelerates atherosclerosis and promotes calcification and medial degeneration. Circ Res 2008;102:1529-1538.
89. Bjorkerud S, Bjorkerud B. Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. Am J Pathol 1996;149:367-380. (Pubitemid 26256326)
90. Abela GS, Aziz K, Vedre A, Pathak DR, Talbott JD, Dejong J. Effect of cholesterol crystals on plaques and intima in arteries of patients with acute coronary and cerebrovascular syndromes. Am J Cardiol 2009;103:959-968.
91. Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010;464:1357-1361.
92. Proudfoot D, Skepper JN, Hegyi L, Bennett MR, Shanahan CM,Weissberg PL. Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ Res 2000;87:1055-1062.
93. Ho-Tin-Noe B, Le Dall J, Gomez D, Louedec L, Vranckx R, El-Bouchtaoui M et al. Early atheroma-derived agonists of peroxisome proliferator-activated receptor-{gamma} trigger intramedial angiogenesis in a smooth muscle celldependent manner. Circ Res 2011;109:1003-1014.
94. Li S, Fan YS, Chow LH, Van Den Diepstraten C, van Der Veer E, Sims SM et al. Innate diversity of adult human arterial smooth muscle cells: cloning of distinct subtypes from the internal thoracic artery. Circ Res 2001;89:517-525. (Pubitemid 34132646)
95. Argmann CA, Sawyez CG, Li S, Nong Z, Hegele RA, Pickering JG et al. Human smooth muscle cell subpopulations differentially accumulate cholesteryl ester when exposed to native and oxidized lipoproteins. Arterioscler Thromb Vasc Biol 2004;24:1290-1296. (Pubitemid 38880023)
96. Curcio A, Torella D, Indolfi C. Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting: approach to therapy. Circ J 2011;75:1287-1296.
97. Schmauss D, Weis M. Cardiac allograft vasculopathy: recent developments. Circulation 2008;117:2131-2141. (Pubitemid 351596195)
98. McNamara CA, Sarembock IJ, Bachhuber BG, Stouffer GA, Ragosta M, BarryWet al. Thrombin and vascular smooth muscle cell proliferation: implications for atherosclerosis and restenosis. Semin Thromb Hemost 1996;22:139-144. (Pubitemid 26239906)
99. Hoofnagle MH, Thomas JA, Wamhoff BR, Owens GK. Origin of neointimal smooth muscle: we've come full circle. Arterioscler Thromb Vasc Biol 2006;26:2579-2581.
100. Perrotta I. Ultrastructural features of human atherosclerosis. Ultrastruct Pathol 2011; Aug 15. [Epub ahead of print].
101. Skalen K, Gustafsson M, Rydberg EK, Hulten LM, Wiklund O, Innerarity TL et al. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature 2002;417:750-754. (Pubitemid 34640629)
102. Tabas I, Williams KJ, Boren J. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 2007; 116:1832-1844. (Pubitemid 350287108)
103. Merrilees MJ, Beaumont BW, Braun KR, Thomas AC, Kang I, Hinek A et al. Neointima formed by arterial smooth muscle cells expressing versican variant V3 is resistant to lipid and macrophage accumulation. Arterioscler Thromb Vasc Biol 2011;31: 1309-1316.
104. Thaunat O, Field AC, Dai J, Louedec L, Patey N, Bloch MF et al. Lymphoid neogenesis in chronic rejection: evidence for a local humoral alloimmune response. Proc Natl Acad Sci USA 2005;102:14723-14728. (Pubitemid 41457123)
105. Grabner R, Lotzer K, Dopping S, Hildner M, Radke D, Beer M et al. Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE2/2 mice. J Exp Med 2009;206:233-248.
106. Lotzer K, Dopping S, Connert S, Grabner R, Spanbroek R, Lemser B et al. Mouse aorta smooth muscle cells differentiate into lymphoid tissue organizer-like cells on combined tumor necrosis factor receptor-1/lymphotoxin beta-receptor NF-kappaB signaling. Arterioscler Thromb Vasc Biol 2010;30:395-402.
107. Jondeau G, Michel JB, Boileau C. The translational science of Marfan syndrome. Heart 2011;97:1206-1214.
108. Borges LF, Touat Z, Leclercq A, Zen AA, Jondeau G, Franc B et al. Tissue diffusion and retention of metalloproteinases in ascending aortic aneurysms and dissections. Hum Pathol 2009;40:306-313.
109. Gomez D, Al Haj Zen A, Borges LF, Philippe M, Gutierrez PS, Jondeau G et al. Syndromic and non-syndromic aneurysms of the human ascending aorta share activation of the Smad2 pathway. J Pathol 2009;218:131-142.
110. Gomez D, Coyet A, Ollivier V, Jeunemaitre X, Jondeau G, Michel JB et al. Epigenetic control of vascular smooth muscle cells in Marfan and non-Marfan thoracic aortic aneurysms. Cardiovasc Res 2011;89:446-456.
111. Jackson V, Olsson T, Kurtovic S, Folkersen L, Paloschi V, Wagsater D et al. Matrix metalloproteinase 14 and 19 expression is associated with thoracic aortic aneurysms. J Thorac Cardiovasc Surg 2011; Sep 26. [Epub ahead of print].
112. Bond M, Chase AJ, Baker AH, Newby AC. Inhibition of transcription factor NF-kappaB reduces matrix metalloproteinase-1,-3 and-9 production by vascular smooth muscle cells. Cardiovasc Res 2001;50:556-565. (Pubitemid 32480249)
113. Williams H, Johnson JL, Jackson CL, White SJ, George SJ. MMP-7 mediates cleavage of N-cadherin and promotes smooth muscle cell apoptosis. Cardiovasc Res 2010;87: 137-146.
114. Johnson JL, Dwivedi A, Somerville M, George SJ, Newby AC. Matrix metalloproteinase (MMP)-3 activates MMP-9 mediated vascular smooth muscle cell migration and neointima formation in mice. Arterioscler Thromb Vasc Biol 2011;31:e35-e44.
115. Katunuma N. Structure-based development of specific inhibitors for individual cathepsins and their medical applications. Proc Jpn Acad Ser B Phys Biol Sci 2011;87: 29-39.
116. Sukhova GK, Shi GP, Simon DI, Chapman HA, Libby P. Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest 1998;102:576-583. (Pubitemid 28376160)
117. Watari M,Watari H, Nachamkin I, Strauss JF. Lipopolysaccharide induces expression of genes encoding pro-inflammatory cytokines and the elastin-degrading enzyme, cathepsin S, in human cervical smooth-muscle cells. J Soc Gynecol Investig 2000;7: 190-198. (Pubitemid 30349165)
118. Cheng C, Tempel D, van Haperen R, van der Baan A, Grosveld F, Daemen MJ et al. Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress. Circulation 2006;113:2744-2753. (Pubitemid 43947992)
119. Pai A, Leaf EM, El-Abbadi M, Giachelli CM. Elastin degradation and vascular smooth muscle cell phenotype change precede cell loss and arterial medial calcification in a uremic mouse model of chronic kidney disease. Am J Pathol 2011;178:764-773.
120. Hamblin M, Chang L, Zhang H, Yang K, Zhang J, Chen YE. Vascular smooth muscle cell peroxisome proliferator-activated receptor-gamma deletion promotes abdominal aortic aneurysms. J Vasc Surg 2010;52:984-993.
121. Linke M, Gordon RE, Brillard M, Lecaille F, Lalmanach G, Bromme D. Degradation of apolipoprotein B-100 by lysosomal cysteine cathepsins. Biol Chem 2006;387: 1295-1303. (Pubitemid 44402077)
122. Taleb S, Cancello R, Clement K, Lacasa D. Cathepsin S promotes human preadipocyte differentiation: possible involvement of fibronectin degradation. Endocrinology 2006;147:4950-4959. (Pubitemid 44402202)
123. Bouton MC, Richard B, Rossignol P, Philippe M, Guillin MC, Michel JB et al. The serpin protease-nexin 1 is present in rat aortic smooth muscle cells and is upregulated in L-NAME hypertensive rats. Arterioscler Thromb Vasc Biol 2003;23:142-147. (Pubitemid 36091639)
124. Richard B, Arocas V, Guillin MC, Michel JB, Jandrot-Perrus M, Bouton MC. Protease nexin-1: a cellular serpin down-regulated by thrombin in rat aortic smooth muscle cells. J Cell Physiol 2004;201:138-145. (Pubitemid 39187052)
125. Matrisian LM, Hogan BL. Growth factor-regulated proteases and extracellular matrix remodeling during mammalian development. Curr Top Dev Biol 1990;24:219-259.
126. Dong C, Zhu S,Wang T, YoonW, Goldschmidt-Clermont PJ. Upregulation of PAI-1 is mediated through TGF-beta/Smad pathway in transplant arteriopathy. J Heart Lung Transplant 2002;21:999-1008. (Pubitemid 35291149)
127. Borges LF, Gomez D, Quintana M, Touat Z, Jondeau G, Leclercq A et al. Fibrinolytic activity is associated with presence of cystic medial degeneration in aneurysms of the ascending aorta. Histopathology 2010;57:917-932.
128. Madureira PA, Surette AP, Phipps KD, Taboski MA, Miller VA, Waisman DM. The role of the annexin A2 heterotetramer (AIIt) in vascular fibrinolysis. Blood 2011; 118:4789-4797.
129. Chen NX, O'Neill KD, Chen X, Moe SM. Annexin-mediated matrix vesicle calcification in vascular smooth muscle cells. J Bone Miner Res 2008;23:1798-1805.
130. Daub B, Schroeter M, Pfitzer G, Ganitkevich V. Expression of members of the S100 Ca2+-binding protein family in guinea-pig smooth muscle. Cell Calcium 2003;33: 1-10. (Pubitemid 36221685)
131. Meilhac O, Ho-Tin-Noe B, Houard X, Philippe M, Michel JB, Angles-Cano E. Pericellular plasmin induces smooth muscle cell anoikis. FASEB J 2003;17:1301-1303.
132. Richard B, Bouton MC, Loyau S, Lavigne D, Letourneur D, Jandrot-Perrus M et al. Modulation of protease nexin-1 activity by polysaccharides. Thromb Haemost 2006; 95:229-235.
133. Rossignol P, Ho-Tin-Noe B, Vranckx R, Bouton MC, Meilhac O, Lijnen HR et al. Protease nexin-1 inhibits plasminogen activation-induced apoptosis of adherent cells. J Biol Chem 2004;279:10346-10356. (Pubitemid 38372642)
134. Kanse SM, Parahuleva M, Muhl L, Kemkes-Matthes B, Sedding D, Preissner KT. Factor VII-activating protease (FSAP): vascular functions and role in atherosclerosis. Thromb Haemost 2008;99:286-289. (Pubitemid 351230957)
135. Muhl L, Nykjaer A, Wygrecka M, Monard D, Preissner KT, Kanse SM. Inhibition of PDGF-BB by factor VII-activating protease (FSAP) is neutralized by protease nexin-1, and the FSAP-inhibitor complexes are internalized via LRP. Biochem J 2007;404:191-196. (Pubitemid 46849590)